Risk Factors associated with Outcome

Slides:



Advertisements
Similar presentations
SRTR Transplant Benefit-Based Liver Allocation Robert M. Merion, MD, FACS OPTN/UNOS Liver Forum Atlanta, GA April 12, 2010.
Advertisements

Clinical Significance of Preoperative 18F-FDG PET Non- Avidity in Papillary Thyroid Carcinoma Do Hoon Koo 1, Ho-Young Lee 2, Kyu Eun Lee 3,4, So Won Oh.
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index American Journal of Transplantation 2006; 6: 783–790 S. Fenga, N.P.
USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.
ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results.
David C. Mulligan, MD, FACS
BWGHF Liège Heart transplantation 2008.
INFLUENCE OF HLA MISMATCH ON GRAFT SURVIVAL IN RENAL TRASPLANTATION IN ADULTS IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo MD., Tagliafichi.
LIVER TRANSPLANTATION- BASICS IN SURGERY
Liver transplant: myths and realities James Trotter, MD Baylor University Medical Center Dallas, Texas.
Region 10 and In situ Split of the Deceased Donor Liver OSOTC Education Conference September 11, 2015.
12/2013 The Present Evolution of Liver Transplantation in Europe EUROPEAN LIVER TRANSPLANT REGISTRY 28 countries institutions 118,441 transplantations.
Multicenter Study of Down-staging of Hepatocellular Carcinoma (HCC) to within Milan Criteria before Liver Transplantation Neil Mehta, MD; Jennifer Guy,
Prevalence of Dry Eye Disease among Elderly Korean Population Sang Beom Han, MD, 1 Joon Young Hyon, MD, 1 Won Ryang Wee, MD, 2,3 Jin Hak Lee, MD, 1, 3.
Andreas A. Rostved, MD Research assistant Department of Surgical Gastroenterology and Transplantation Rigshospitalet – Copenhagen University Hospital Denmark.
Quebec experience from 2003 to 2009 M Carrier MD, JF Lize MD and Quebec transplant programs Impact of Expanded Criteria Donors on outcomes of recipients.
Making the Most at the Margins Improving Organ Utilization and Recipient Outcomes. Jared C Brandenberger MD UNOS Region 6 Educational Forum March 6, 2015.
Clinical Features and Outcome of Primary Amyloidosis in Korea Kihyun Kim, Seok Jin Kim, Hyun Jung Jun,Yeung-Chul Mun, Chul Soo Kim, Jong-Ho Won, Soo-Mee.
Impact of Recipient and Donor Non-immunological factors on the Outcome of Expanded Criteria Deceased Donors Kidney Transplantation Dr Hajar Al Hayyan.
A2ALL When Using A2ALL Slides We welcome the use of A2ALL slides, as we value the distribution of our research for the benefit of patient care and transplant.
Liver transplantation for HCV infection R3 양 인 호 /Prof 김 병 호.
Treatment Strategy for Recurrent Hepatocellular Carcinoma: Salvage Transplantation, Repeated Resection, or Radiofrequency Ablation? Albert C. Y. Chan,
심 재 준심 재 준 Am J Gastroenterol 2007;102:
Organ Failure in Nepal: Rapidly Growing Challenge for All
Living Donor Transplants
Strategies to increase transplantation
Outcomes of bariatric surgery after renal transplant: single center experience in Kuwait Authors Gheith O, Al-Otaibi T, Nampoory MRN, Halim M, Saied T,
Living donor liver transplantation: Eastern experiences
PCI related in-hospital mortality based on race and gender in the USA
SD Walter MD1, T Mahten MD2, JW Harbour MD1,3
Cirrhotic Ascites Patient Population Survey in Korea
HCV & liver transplantation
Number of transplants, by donor type figure 8.1
Nalaka Gunawansa, John McCall, Stephen Munn, Peter Johnston
P689 THE ROLE OF NUTRITIONAL ASSESSMENT FOR SIMULTANEOUS
International Neurourology Journal 2011;15:
Donor age still matters in liver transplantation
T. Rana, L. Szabo, A. Asderakis, E. Ablorsu
Liver Transplantation: 50 years
Liver only transplants in the UK Question 2: In terms of survival benefit.
The 44th Congress of the Korean Association of HBP Surgery
(1) Donor and Transplant Activity There has been an increase in the number of liver donors since 2007/08, with a concurrent mean 12% increase in.
Improved survival outcomes after resection of ductal adenocarcinoma in the body and tail of the pancreas: A single center 10 years’ experience Seong.
EUROPEAN LIVER TRANSPLANT REGISTRY
Left ventricular dilatation, the presence of intra-cardiac thrombus and short term outcome for primary heart graft failure patients managed with ECMO.
HEPATOCELLULAR CARCINOMA (HCC) at
Risk factors in deceased-donor transplants Risk factor 1988
Risk factors for stone recurrence after laparoscopic common bile duct exploration of CBD stones Chul Woong Kim, Ju Ik Moon, In Seok Choi Department of.
Gi-Won Song, Gi-Young Ko, Dong-Il Gwon
Recent Advances in Liver Transplantation
Impact of metabolic risk factors on HCC
Cystic Neoplasm of the Pancreas Clinical Review of 60 Cases and Treatment Strategy D.K.Kim, S.I.Noh, J.S.Heo, J.H.Noh, T.S.Sohn, S.J.Kim, S.H.Choi, J.W.Joh,
Epidemiology & First option of treatment
Proposal to Delay the HCC Exception Score Assignment
Volume 68, Issue 5, Pages (November 2005)
Does Liver Regeneration Increase the Postoperative HCC Recurrence after Curative Resection ? Jin-Ho Lee, MD. Department of Surgery, Yonsei University.
Kidney and Kidney/Pancreas Transplantation in a Year
Patient characteristics: American vs Canadian transplant patients
Proposal to Delay the HCC Exception Score Assignment
Eldar Ahmadov, Mirjalal Kazimi, Kamran Beydullayev, Ceyhun Isayev, Mail Sadiyev Department of Surgery and Organ Transplantation, Central Hospital of Oil.
Bile duct invasion itself can be the prognosis factor in early HCC
Volume 87, Issue 3, Pages (March 2015)
The 44th Congress of the Korean Association of HBP Surgery
The SUV on 18F-FDG-PET/CT imaging as an independent predictor for overall survival and disease free survival after hepatectomy of Hepatocellular carcinoma(
Number of Donors in Australia
Prognostic effect of complete pathologic response following TACE on HCC patients undergoing liver resection or transplantation Prognostic effect of complete.
Results of Living Donor Age of Sixth Decade for Adult Liver Transplantation Using a Right Lobe graft Seok-Hwan Kim.
Surgical resection of metachronous liver metastases
Survival of End Stage Renal Failure Patients with Cancer
Presentation transcript:

Risk Factors associated with Outcome in Korean Split-Liver transplantation Analysis of the 10-year Korean Network for Organ Sharing data base I will present my study, Outcome of Split-Liver Transplantation in Korea : Analysis of the KONOS Database Kyung Chul Yoon2 Sanghee Song1, Ok-Kyung Kim1, Ok Soo Kim1, Nam-Joon Yi2, Hyeyoung Kim2, Suk Kyun Hong2, Kyung Chul Yoon2, Hyo-Sin Kim2, Kwang-Woong Lee2 and Kyung-Suk Suh2 .1Organ Transplantation Center, Seoul National University Hospital, 2Department of Surgery, Seoul National University College of Medicine, Seoul, Korea

SLT in KOREA SLT (split liver transplantation): 5% of DDLT cases The number of Split liver transplantation cases has increased in the past years: less than 5 cases in 2005 to 20 cases in 2014. The proportion of SLT in DDLT cases is 5%. The most common type of split is adult with child. SLT (split liver transplantation): 5% of DDLT cases In SLT cases, Adult/Child splitting: 90-95%

Indication for SLT Criteria of deceased donor 1) Hemodynamic stable DBD donor 2) Age ≤ 40, Body weight ≥ 50kg 3) Inotrophics : Dopamin ≤ 15㎍/kg/min, dobutamin ≤ 15㎍/kg/min, norepinephrine ≤ 0.75㎍/kg/min, epinephrine ≤ 0.075㎍/kg/min no limit of vasopressin Criteria of Child recipient 1) Age <16 2) Body weight ≤ 30㎏ 3) ≤ Left lateral section Criteria of Adult recipient  No criteria When a deceased donor occurs, KONOS checks whether or not if the donor’s liver can be split with this criteria. Hemodynamic stable DBD donor, age less than 40, and weight greater than 50 kg, and the use of inotropics. Child recipient can be on a waiting list according to the following criteria: Age less than 16, body weight less than 30kg. However, adult recipient criteria has not yet been decided.

Outcome of SLT Lee et al . Am J tranpl. 2008 Overall survival (OS) Similar or worse than whole liver DBD LT 5yr survival rate: 72% vs 65% on SRTR data Lee et al . Am J tranpl. 2008 Complication - Similar or more common in SLT than whole liver DBD LT ( esp. biliary, hepatic a. ) Risk factors of outcome - Recipient factors - Age, UNOS Status, ABOi, dialysis, tumor.. - Donor factors – Age, weight, cold ischemic time. - Technical factor – Small volume center, Ex situ technique Outcomes in Korea have not been reported. There are some studies for OS and complication in SLT Overall survival was simiar or worse outcomes on SRTR data comparing whole LT. and complication rate also similar or worse oucomes than whole liver transplantation. Especially biliary problem and , Hepatic a. thrombosis..   These are some of the known risk factors, and it is similar with whole liver transplantation. recipient’s age and status, donor age and weight, and ischemic time. And ex situ technique. But Outcomes in Korea have not been reported as yet Lauterio A et al. World J Gastroentrol. 2009 Lee et al . Am J tranpl. 2008

Purpose 1. Overall survival of Korean SLT 2. Factors affecting patient overall survival   So we analyzed overall survival of Korean SLT and factors affection patient overall survival.

Method Retrospectively reviewed 2005-2014 for 10 years KONOS Data base of 23 centers, - 200 cases (adult n=107 / child n=93) - Exclusion criteria: status 1 d/t reLT (n=4) Seoul National University Hospital data - Adult Whole liver LT (n=322), Child LDLT(n=85) - Exclusion criteria: reLT (n=18), LT with KT (n=3) Analysis for risk factors, Overall survival 1. Adult SLT (104 in KONOS) vs Adult whole liver (303 in SNUH) 2. Child SLT (92 in KONOS) vs Child LDLT (85 in SNUH)

Graft Volume Issue in Adult SLT DRWR (Donor Weight : Recipient Weight) - KONOS to match recipient: 0.5 ≤ DRWR ≤ 2 - GV: recipient ideal LV 50~200% Whole Liver LT DRWR 1 GV = 100% recipient LV* SLT DRWR 1, GV (right/left liver) = 65% / 35% recipient LV adjusted DRWR (aDRWR) = 0.65 or 0.35 X DRWR Before comparing split and whole Liver Transplantation, we adjusted DRWR. DRWR is donor weight and recipient weight ratio and it is used by KONOS to match recipient. if there are recipient whose DRWR is 1, we assume that the recipient can get 100% recipient liver volume. But in case of Split, DRWR 1 does not mean the same graft volume, so we multiply 0.65 in right split group and or 0.35 in Left split group by DRWR. GV: graft volume; LV: liver volume

Demographics Adult : SLT vs Whole LT  Factors Split (n=104) Whole (n=303) p- value Recipient   Age (year) 53 ± 10 53 ± 11 0.974 Male Gender 59 (56.7) 188 (62%) 0.354 Weight (kg) 61.9 ± 11.8 60.11 ± 13 0.222 Diagnosis <0.001 HBV 54 (51.9%) 85 (28.1%) HCV 4 (3.8%) 11 (3.6%) Alcohol 13 (12.5%) 51(12.9%) Cholestatic 2 (1.9%) 8 (2.6%) Malignancy 5 (4.8%) 110 (36.3%) Fulminant 12 (11.5%) 15 (5%) Others 14 (13.5%) 22 (7.3%) KONOS status 0.071 1 5(4.8%) 21 (6.9%) 2A 49 (47.1%) 172 (56.8%) 2B 45 (43.3%) 96 (31.7%) 3 6 (2%) Factors  Split (n=103) Whole (n=303) p- value Donor   Age (year) 25.1 ± 8 42.9 ± 14.6 (missing 18 %) <0.001 Male 74 (71%) 153 (50.5%) (missing 18 %) 0.112 D-weight (kg) 67.7 ± 15.6 65.19 ± 14.8 (missing 42 .5%) 0.167 DRWR 1.13 ± 0.3 1.12 ± 0.3 (missing 43%) 0.848 aDRWR or DRWR 0.69 ± 0.19 1.12 ±0.3 (missing 43%) This is the demographics of the split and whole liver. The recipients’ diagnosis was somewhat different, especially HBV fulminant hepatitis was more common in the SLT group while malignancy was more common in the whole liver group. The status was not significantly different. The donor’s age was of course lower in split group

Adult OS : SLT vs Whole LT Split had worse outcomes than the whole liver group. and 5yr survival was 66% 1 yr 3 yr 5 yr HR p-value Whole liver (n=303) 87.1 80 78 Reference Split liver (n=104) 72.5 68 66 1.881(1.237 – 2.861) 0.003

Risk factors for OS in DDLT Uni p-value Multi p-value HR (95% CI) Recipient factor   - Age ≤ 56 (year) > 56 0.005  0.126  Reference 1.478 ( 0.896 – 2.438) - Weight ≤55 (kg) >55 0.015  0.076 1.721 ( 0.945 - 3.134) - Split Whole 0.011  0.306 1.368 (0.751 – 2.491) Reference  - Status 0.078 1 ( 10/ 26, 38.5%) not 1 ( 84 / 373, 18% ) 0.064 0.02 2.710 (1.168 – 6.288) Reference - aDRWR or DRWR ≤ 1.23 ( 38/ 103, 35%) >1.23 ( 30 / 175, 18% ) 0.001 2.273 (1.402 – 3.683)

Adjusted OS in Adult DDLT SLT vs Whole LT After that, Adjusted OS between split and whole liver was not different. p-value = 0.345   HR (95%CI) P value Status 1 2.710 (1.168 – 6.288) 0.02 aDRWR or DRWR< 1.23 2.273 (1.402 – 3.683) 0.001

Demographics Child: SLTvs LDLT   Child SLT (n=92) Child LDLT (n=85) p-value Recipient Age (yr) 3.29 ± 3.92 5.38±5.62 <0.001 Male Gender 35 (38%) 43 (50.6%) 0.098 R-weight (kg) 13.1 ± 10 25.0 ± 17 Diagnosis 0.001 Cholestatic 50 (54.8%) 48 (56.5%) Malignant 2 (2.2%) 5 (5.9%) Fulminant 13 (15.3%) Others 38 (41.3%) 19 (22.4%) Status 0.005 1 9 (9.8%) 12 (15.8%) 2B 57 (62%) 28 (36.8%) 3 26 (28.3%) 36 (47.4%) Ischemic Time (min) 258 ± 274 (missing 40) 71 ± 37 (missing 26) Donor 24.8 ± 7.82 35.3 ± 6.88 65 (70.7%) 35 (41.2%) D-weight (kg) 64.6 ± 13.9 61.3± 8.46 Ill move to the children cases. Recipient age, weight, is lower in SLT group and fulminant hepatitis and status 1 cases is more in LDLT group. Ischemic time is of couse longer in SLT group and donor age and gender, donor weight are different.

Child OS: SLT vs. LDLT 1yr 3yr 5yr HR (95% CI) p-value LDLT (n=92) Child overall survival was worse in SLT group. 1yr 3yr 5yr HR (95% CI) p-value LDLT (n=92) 96.2 93.7 Reference 0.044 SLT (n=85) 87.9 86 83.5 2.862 ( 1.029 – 7.958)

Risk factors for OS in Children Uni p-value Multi p -value HR (95%) Recipient   Age 0.093 Weight <20 kg >20kg 0.061 0.302  3.268 ( 0.346 – 30.908) Reference Status 0.832 status 1 not status1 0.686 Diagnosis Cholestatic (2 / 100, 2%) not cholestatic (17 / 79, 25%) <0.001 0.008 7.992 (1.737 – 36.738) Donor factor Donor age <30 >30 0.006 0.072 4.359 (0.879 – 21.616) Male Gender 0.037 0.206  2.768 (0.572 – 13.398) Graft factor Split SLT LDLT 0.053 0.111  4.088 (0.724 – 23.071) Ischemic time (min) ≤360 8/107 (7.5%) >360 4/6 (66.7%) 0.001  0.002  7.257 ( 2.031 – 25.928)

Adjusted OS in Children p-value = 0.111 After that adjusted OS was not different between split and LDLT.   HR (95%CI) p-value Not cholestatic 7.992 (1.737 – 36.738) 0.008 Ischemic time >360 7.257 (2.031 – 25.928) 0.002

Summary and Conclusion 1. Adult: SLT vs Whole liver LT 1) Adjusted split recipient OS is comparable to that of whole LT. 2) Status 1 and graft volume are risk factors in DDLT. 3) DRWR in whole liver LT and aDRWR in SLT > 1.23 could lead better survival. 2. Child: SLT vs LDLT 1) Adjusted split recipient OS is comparable to that of LDLT. 2) Cholestatic liver disease and short ischemic time (≤360min) have better OS.

Thank you for your attention